Education
About Us
Working with TipRanks
Follow Us
Sotera Health (SHC)
NASDAQ:SHC
Earnings Data
Report Date
May 01, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.12Last Year’s EPS
0.13Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 27, 2025
|% Change Since: -13.42%
|Next Earnings Date:May 01, 2025
Earnings Call Sentiment|Neutral
Sotera Health demonstrated resilience with consistent annual revenue growth and strong adjusted EBITDA margins for 2024. Strategic refinancing and progress in cobalt projects showcase positive long-term planning. However, the fourth quarter faced challenges with revenue and income declines in specific segments like Nordion and Nelson Labs, reflecting some volatility and market challenges.Company Guidance
During Sotera Health's fourth quarter and full year 2024 conference call, the company provided guidance for 2025, anticipating total company revenue growth in the range of 4% to 6% on a constant currency basis, aligning with their long-term guidance range of 5% to 7%. The adjusted EBITDA is expected to grow between 4.5% and 6.5% on a constant currency basis. The company outlined expected pricing strategies with Sterigenics on the higher end of a 3% to 4% range, while Nelson and Nordion are on the lower end. The anticipated capital expenditures for 2025 are projected between $190 million and $210 million, with a focus on organic growth and deleveraging. Sotera Health also plans to achieve $500 million to $600 million in free cash flow over the next three years, with no major mergers or acquisitions assumed in their guidance.Consistent Revenue Growth
Sotera Health reported top and bottom line growth for the full year 2024, with $1.1 billion of revenue, marking the nineteenth consecutive year of annual revenue growth.
Adjusted EBITDA and Margin Stability
The company delivered approximately 50% adjusted EBITDA margins for 2024, with adjusted EBITDA growing by 3.9% or 4.6% on a constant currency basis.
Strategic Refinancing
Sotera Health successfully refinanced its capital structure, extending maturities to 2031, and ended the year with strong liquidity.
Growth in Embedded Labs and Expert Advisory Services
Embedded Labs and expert advisory services both realized double-digit revenue growth versus 2023, demonstrating cross-business unit synergies.
Cobalt Development Progress
Nordion grew revenue to upper single digits for the year and made progress on cobalt development projects, with the first installation of cobalt into a Darlington reactor.
---
SHC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SHC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 27, 2025 | $13.64 | $12.28 | -9.97% |
| Nov 05, 2024 | $15.80 | $15.42 | -2.41% |
| Aug 05, 2024 | $13.22 | $14.22 | +7.56% |
| May 02, 2024 | $11.27 | $10.91 | -3.19% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Sotera Health (SHC) report earnings?
Sotera Health (SHC) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
What is Sotera Health (SHC) earnings time?
Sotera Health (SHC) earnings time is at May 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SHC EPS forecast?
SHC EPS forecast for the fiscal quarter 2025 (Q1) is 0.12.
---